Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Clinical trial NCT01100684 · COMPLETED
Trial details
- NCT number
- NCT01100684
- Sponsor
- Tioga Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2013-06-01
- Enrollment
- 611
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.